Tests the Virtuoso endoscopy system for removing bladder lesions
Tests a robotic endoscope system for removing bladder growths in adults.
Plain-language title generated from the registry record
Registry title: Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial
Key facts
- Where
- Hong Kong, Hong KongSee the site
Where in Hong Kong
- Prince of Wales Hospital, Chinese University of Hong KongHong Kong, Hong KongNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Virtuoso Surgical, Inc.
- Trial code
- NCT06940648
- Record updated
- 29 June 2026
- Original description
A robotic assisted surgery for bladder lesion excision.Read full original descriptionShow less
Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial
A robotic assisted surgery for bladder lesion excision.
Inclusion: The subject is 22 years or older; The subject is eligible and fit for transurethral bladder lesion removal and/or biopsy and has an appropriate indication to go through this surgery; The subject is willing and able to provide written informed consent and comply with the study protocol; The subject can undergo general anesthesia per anesthesiologist assessment; The subject's planned aggregated bladder lesion(s) excision specimens are smaller than 3 cm.
Exclusion: The subject is receiving anticoagulants and is unable or not willing to cease the medication for the investigational procedure; The subject has a urethral abnormality, implant, or previous surgery which would conflict with the procedure; The subject has undergone a transurethral bladder resection procedure in the past 6 months; Bladder tumor detected during intravesical therapy; Previous histological diagnosis different than non-muscle invasive bladder cancer; Presence or prior history of upper urinary tract malignancy; The subject has acute untreated urinary tract infection or urosepsis; The subject has a documented nickel allergy or nickel sensitivity; The subject has a history of radiation treatment within the pelvis; History of bleeding disorder, coagulation abnormality, or use of anticoagulants; The presence of other active malignancy; The subject is confirmed to be or suspected to be pregnant; The subject belongs to a vulnerable group (prisoner, etc.); Bladder tumor base maximal dimension is greater than 3 cm; Eastern Cooperative Oncology Group performance status greater than or equal to 3; American Society of Anesthesiologists physical status classification of IV or above; Life expectancy <1 yr.